Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
Titel:
Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
Auteur:
Sonnenblick, Amir Francis, Prudence A. Azim Jr., Hatem A. de Azambuja, Evandro Nordenskjöld, Bo Gutiérez, Jorge Quinaux, Emmanuel Mastropasqua, Mauro G. Ameye, Lieveke Anderson, Michael Lluch, Ana Gnant, Michael Goldhirsch, Aron Di Leo, Angelo Barnadas, Agusti Cortes-Funes, Hernan Piccart, Martine Crown, John